ReviewGenes2025

Liquid Biopsy and Challenge of Assay Heterogeneity for Minimal Residual Disease Assessment in Colon Cancer Treatment.

Giovanni CrisafulliPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.